Zum Hauptinhalt springen

Fachveröffentlichungen

18. April 2025 | Fachveröffentlichungen

Does Cannabis Use Contribute to Schizophrenia? A Causation Analysis Based on Epidemiological Evidence.

Does Cannabis Use Contribute to Schizophrenia? A Causation Analysis Based on Epidemiological Evidence. Pourebrahim S, Ahmad T, Rottmann E, Schulze J, Scheller B. Biomolecules. 2025 Mar 4;15(3):368. doi: 10.3390/biom15030368. PMID: 4014…

18. April 2025 | Fachveröffentlichungen

The Pharmacology of Cannabinoids in Chronic Pain.

The Pharmacology of Cannabinoids in Chronic Pain. Cortez-Resendiz A, Leiter TJ, Riela SM, Graziane NM, Raup-Konsavage WM, Vrana KE. Med Cannabis Cannabinoids. 2025 Feb 5;8(1):31-46. doi: 10.1159/000543813. PMID: 40046175; PMCID: PMC118…

18. April 2025 | Fachveröffentlichungen

Cannabinoid Hyperemesis Syndrome: A Rising Complication.

Cannabinoid Hyperemesis Syndrome: A Rising Complication. Peles S, Khalife R, Magliocco A. Cureus. 2025 Feb 13;17(2):e78958. doi: 10.7759/cureus.78958. PMID: 40091958; PMCID: PMC11910202. https://pmc.ncbi.nlm.nih.gov/articles/PMC11910202/

18. April 2025 | Fachveröffentlichungen

Methadone and Buprenorphine as Medication for Addiction Treatment Diversely Affect Inflammation and Craving Depending on Their Doses.

Methadone and Buprenorphine as Medication for Addiction Treatment Diversely Affect Inflammation and Craving Depending on Their Doses. Leventelis C, Veskoukis AS, Rojas Gil AP, Papadopoulos P, Garderi M, Angeli A, Kampitsi A, Tsironi M. …

18. April 2025 | Fachveröffentlichungen

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder.

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder. Nosyk B, Min JE, Homayra F, et al. JAMA. 2024;332(21):1822–1831. doi:10.1001/jama.2024.16954 https://jamanetwork.com/journals/jama/fullarticl…

18. April 2025 | Fachveröffentlichungen

Initiation and Dosing of Extended-Release Buprenorphine: A Narrative Review of Emerging Approaches for Patients Who Use Fentanyl.

Initiation and Dosing of Extended-Release Buprenorphine: A Narrative Review of Emerging Approaches for Patients Who Use Fentanyl. Lee KW, Mead A, Ghauri I, Hollett B, Drolet M, Kozicky JM. Subst Abuse Rehabil. 2025 Mar 25;16:71-82. doi…

18. April 2025 | Fachveröffentlichungen

Trends in Extended-Release and Non-Extended-Release Buprenorphine Dispensing.

Trends in Extended-Release and Non-Extended-Release Buprenorphine Dispensing. Stopka TJ, Dalvi N, Young LD, Shrestha S, Valerio DD, Walley AY. JAMA Netw Open. 2025 Apr 1;8(4):e253158. doi: 10.1001/jamanetworkopen.2025.3158. PMID: 40184…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten